Evolv Technologies
EVLV
4.65
-0.05
-0.96%
Evolv Technologies
US · EVLV
#3367 by market cap
4.65
-0.05
-0.96%
Live - 5344 symbols - heartbeat 194s ago
· 2026-10-08 10:00
Pre-market
4.71
+0.44%
After-hours
4.70
+0.21%
Overnight
4.66
-0.64%
- Market cap
- 841.33M
- P/E (TTM)i
- -232.25
- P/Bi
- 7.08
- EPSi
- -0.20
- Div yieldi
- 0.00%
- 52W posi
- 4%
Reader sentiment
Are you bullish or bearish on EVLV?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.04, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 7 years
Latest year +40.48% YoY
Margins
- Gross margin
- 51.61%
- Operating margin
- -31.39%
- Net margin
- -22.71%
Key ratios & quality
- Enterprise valuei
- 803.88M
- Altman Z-Scorei
- 1.04
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 5.85M | 4.79M | 23.39M | 52.72M | 79.57M | 103.87M | 145.91M |
| Gross profit | 552.00K | 1.29M | 4.03M | 1.40M | 31.91M | 59.46M | 75.30M |
| Selling & admin expenses | 10.46M | 12.48M | 44.65M | 84.65M | 97.17M | 117.24M | 100.48M |
| Research & development | 8.50M | 15.71M | 11.46M | 18.54M | 24.47M | 23.45M | 20.62M |
| Operating profit | -18.40M | -26.90M | -53.40M | -101.79M | -89.73M | -81.22M | -45.80M |
| Pretax profit | -19.86M | -27.39M | -10.89M | -86.80M | -108.00M | -54.02M | -33.08M |
| Tax | -- | -- | -- | 0 | 51.00K | 0 | 62.00K |
| Net profit | -19.86M | -27.39M | -10.89M | -86.80M | -108.05M | -54.02M | -33.14M |
| Basic EPS | 0 | 0 | 0 | -1 | -1 | 0 | 0 |
| Diluted EPS | -0.14 | -0.19 | -0.15 | -0.60 | -0.72 | -0.34 | -0.20 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 32.01M | 32.54M | 42.85M | 38.50M | 46.33M | 43.75M |
| Gross profit | 19.15M | 16.22M | 21.31M | 18.63M | 23.60M | 21.95M |
| Selling & admin expenses | 19.74M | 20.91M | 21.99M | 37.85M | 23.34M | 23.33M |
| Research & development | 4.86M | 4.74M | 5.61M | 5.41M | 5.89M | 5.78M |
| Operating profit | -5.45M | -9.43M | -6.29M | -24.64M | -5.62M | -7.16M |
| Pretax profit | -1.63M | -40.54M | -1.80M | 10.88M | -5.05M | -9.30M |
| Tax | 63.00K | -1.00K | 0 | 0 | -37.00K | 0 |
| Net profit | -1.69M | -40.54M | -1.80M | 10.88M | -5.01M | -9.30M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.01 | -0.25 | -0.01 | 0.06 | -0.03 | -0.05 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total current assets | 20.31M | 10.31M | 331.12M | 292.58M | 173.36M | 121.45M | 151.30M |
| Cash & ST investments | 17.34M | 4.70M | 307.70M | 230.12M | 118.82M | 51.94M | 69.04M |
| Inventory | 1.36M | 2.74M | 2.89M | 10.26M | 10.34M | 16.96M | 9.32M |
| Total assets | 24.40M | 21.36M | 362.86M | 348.12M | 297.13M | 268.06M | 304.41M |
| Total current liabilities | 9.33M | 12.12M | 24.33M | 59.13M | 81.30M | 96.71M | 122.98M |
| Short-term debt | 3.65M | 227.00K | 2.00M | 11.11M | 1.39M | 2.20M | 2.99M |
| Long-term debt | -- | 16.43M | 7.95M | 19.68M | -- | -- | 28.60M |
| Total liabilities | 82,910,000.00 | 106,041,000.00 | 72,583,000.00 | 121,130,000.00 | 152,989,000.00 | 150,408,000.00 | 184,987,000.00 |
| Total equity | -58.51M | -84.69M | 290.27M | 226.99M | 144.14M | 117.65M | 119.42M |
| Retained earnings | -66.49M | -93.88M | -105.80M | -192.21M | -300.65M | -354.66M | -387.80M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 103.77M | 133.08M | 151.64M | 151.30M | 151.98M | 149.41M |
| Cash & ST investments | 35.02M | 36.94M | 56.23M | 69.04M | 61.07M | 62.63M |
| Inventory | 10.06M | 12.14M | 8.77M | 9.32M | 8.26M | 8.66M |
| Total assets | 255.98M | 280.42M | 304.29M | 304.41M | 304.64M | 302.02M |
| Total current liabilities | 94.40M | 142.89M | 119.35M | 122.98M | 125.86M | 126.85M |
| Short-term debt | 2.42M | 2.72M | 2.77M | 2.99M | 3.12M | 3.12M |
| Long-term debt | -- | -- | 28.53M | 28.60M | 28.67M | 28.74M |
| Total liabilities | 134,921,000.00 | 187,772,000.00 | 202,053,000.00 | 184,987,000.00 | 183,965,000.00 | 183,165,000.00 |
| Total equity | 121.06M | 92.65M | 102.24M | 119.42M | 120.67M | 118.86M |
| Retained earnings | -356.35M | -396.89M | -398.68M | -387.80M | -392.81M | -402.11M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -15.18M | -23.25M | -56.78M | -74.74M | -9.80M | -30.85M | 18.67M |
| Depreciation & amortization | 535.00K | 1.07M | 2.90M | 5.44M | 9.70M | 17.38M | 24.34M |
| Free cash flow | -15.91M | -29.86M | -74.37M | -98.92M | -82.47M | -68.17M | -18.33M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | 0 | 300.00M | -- | -- | -- | -- |
| Ending cash balance | 17.34M | 4.70M | 308.17M | 230.06M | 67.44M | 37.02M | 49.15M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -2.54M | 2.11M | 3.52M | 15.57M | -3.18M | 11.90M |
| Depreciation & amortization | 5.53M | 5.79M | 6.54M | 6.48M | 6.80M | 7.14M |
| Free cash flow | -16.83M | -2.01M | -11.49M | 12.00M | -8.14M | 2.09M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 25.09M | 36.94M | 31.50M | 49.15M | 56.08M | 53.43M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -10.53 | -33.37 | -56.93 | -40.93 | -27.96 |
| ROA %i | -81.38 | -119.73 | -5.65 | -24.30 | -32.85 | -19.06 | -11.58 |
| ROIC %i | -- | -- | -4.09 | -31.77 | -55.03 | -40.70 | -22.42 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -34.32 |
| EBIT margin %i | -326.34 | -563.47 | -20.10 | -155.26 | -131.25 | -52.01 | -21.48 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | 2.18 | 0.85 | 13.61 | 4.95 | 2.13 | 1.26 | 1.23 |
| Quick ratioi | 1.96 | 0.50 | 12.97 | 4.48 | 1.74 | 0.84 | 0.94 |
| Debt / assetsi | 14.94 | 78.01 | 2.74 | 9.10 | 0.47 | 5.42 | 13.88 |
| LT debt / equityi | -- | -- | 2.74 | 9.06 | -- | 10.48 | 32.87 |
| Interest coveragei | -24.49 | -62.70 | -0.78 | -120.36 | -161.39 | -- | -18.10 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 108.15 | 155.24 | 64.36 | 40.40 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -33.84 | -71.94 | -51.67 | -27.96 | -30.16 | -4.94 |
| ROA %i | -16.51 | -32.20 | -20.50 | -11.58 | -13.01 | -1.79 |
| ROIC %i | -33.04 | -68.47 | -41.94 | -22.42 | -23.77 | -2.62 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -39.03 | -72.99 | -43.20 | -21.48 | -21.10 | -0.93 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 1.10 | 0.93 | 1.27 | 1.23 | 1.21 | 1.18 |
| Quick ratioi | 0.75 | 0.56 | 0.89 | 0.94 | 0.83 | 0.83 |
| Debt / assetsi | 5.63 | 5.09 | 13.93 | 13.88 | 13.78 | 13.76 |
| LT debt / equityi | 9.90 | 12.47 | 38.77 | 32.87 | 32.20 | 32.35 |
| Interest coveragei | -44,370.00 | -88,324.00 | -82.58 | -18.10 | -12.55 | -0.44 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Develops, manufactures, markets and sells security screening products and specific services100.00%
Quote time 2026-10-08 10:00:17 · For reference only, not investment advice and not tailored to your situation.